Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Diphenylalkylamine derivative with cardioprotective properties characterized

Jan. 29, 1998

Antihypertensive efficacy described for Novartis' dual ACE/NEP inhibitor

Jan. 28, 1998

In vivo efficacy reported for angiotensin II blocker

Jan. 28, 1998

FDA panel recommends approval of Verdia

Jan. 28, 1998

Rate-independent profile of antiarrhythmic agent suggests improved therapeutic potential

Jan. 28, 1998

Indole endothelin antagonists prepared at Pfizer

Jan. 28, 1998

AtheroGenics initiates phase I testing for new cardiovascular drug

Jan. 27, 1998

New ET antagonists from Merck KGaA bearing a benzothiadiazole functionality

Jan. 27, 1998

U.K. launch for Posicor

Jan. 27, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...